Jazz Pharmaceuticals (JAZZ) Other Accumulated Expenses (2010 - 2012)

Jazz Pharmaceuticals' Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $18.9 million for Q2 2012.

• On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $18.9 million in Q2 2012; TTM through Jun 2012 was $18.9 million, a N/A change from a year earlier, with the FY2011 full-year figure at $2.4 million, up 135.65% from the prior year.
• Other Accumulated Expenses grew to $18.9 million in Q2 2012 per JAZZ's latest filing, from $8.2 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $18.9 million in Q2 2012 and bottomed at $1.0 million in Q4 2010.
• The 3-year median for Other Accumulated Expenses is $5.3 million (2011), against an average of $7.6 million.
• Biggest YoY gain for Other Accumulated Expenses was 135.65% in 2011; the steepest drop was 135.65% in 2011.
• Year by year, Other Accumulated Expenses stood at $1.0 million in 2010, then jumped by 135.65% to $2.4 million in 2011, then surged by 673.8% to $18.9 million in 2012.
• Per Business Quant, the three latest JAZZ Other Accumulated Expenses figures stand at $18.9 million (Q2 2012), $8.2 million (Q1 2012), and $2.4 million (Q4 2011).